Acuity Spatial Genomics, Inc
Serdar Tulu is a staff scientist at Acuity Spatial Genomics, Inc. since March 2023, focusing on developing spatial multiomics systems and managing assay development projects. Prior to this, Tulu worked as a Scientist IV at Veranome Biosystems LLC, where expertise in fluorescence in-situ hybridization assays for spatial transcriptomics and collaboration with software and hardware teams was demonstrated. As an Image Analysis Scientist at Advanced Cell Diagnostics, Tulu specialized in RNA localization analysis, scientific reporting, and customer interactions. Previous roles include research at Stanford University and Duke University, where Tulu investigated bone density effects, advanced methodologies in embryogenesis, and contributed to the understanding of cellular mechanisms. Tulu holds a Ph.D. in Cell Biology from the University of Massachusetts Amherst and a BS in Molecular Biology and Genetics from Boğaziçi University.
Acuity Spatial Genomics, Inc
Acuity Spatial Genomics, Inc. provides a ground-breaking platform designed for simultaneous, genome-wide visualization of the 3D genome in single cells and opens new frontiers in spatial multiomic analyses for discovery. Based on patented technologies developed at Harvard University, the company’s OligoFISSEQ and OligoFISSEQ HD technologies empower researchers to visualize the genome organization and 3D chromatin architecture of individual cells, directly in situ, and in an accessible time-to-result and cost-effective approach. The Acuity technology platform enables the possibility to delve deeper and gain critical insight into transcription regulatory programs that drive cell type, state, function, and pathogenesis—and thus advance discovery in areas such as oncology, neuroscience, and disease research. The company has facilities in Massachusetts and California.